Phosphoinositide 3 Kinase (pi3k) - Pharma

Relevant Publications

CUX1 attenuates the apoptosis of renal tubular epithelial cells induced by contrast media through activating the PI3K/AKT signaling pathway.

Issue Release: 2024

Curative effects and mechanisms of AG1296 and LY294002 co-therapy in Angiostrongylus cantonensis-induced neurovascular unit dysfunction and eosinophilic meningoencephalitis.

Issue Release: 2024

Scorpiones, Scolopendra and Gekko Inhibit Lung Cancer Growth and Metastasis by Ameliorating Hypoxic Tumor Microenvironment via PI3K/AKT/mTOR/HIF-1α Signaling Pathway.

Issue Release: 2024

Thymol as adjuvant in oncology: molecular mechanisms, therapeutic potentials, and prospects for integration in cancer management.

Issue Release: 2024

C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.

Issue Release: 2024

Identification and evolution of PDK-1-like involving lamprey innate immunity.

Issue Release: 2024

PKC-α IS INVOLVED IN THE SIGNALING OF PHAGOCYTOSIS INDUCED BY TWO SNAKE VENOM SECRETORY PLAS IN MACROPHAGES.

Issue Release: 2024

Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer.

Issue Release: 2024

Identification of collagen subtypes of gastric cancer for distinguishing patient prognosis and therapeutic response.

Issue Release: 2024

Case report: Phosphoinositide 3-kinase inhibitor with fulvestrant in a patient with ER+/HER2- metastatic breast carcinoma induced fatal arrhythmias: a preventable event?

Issue Release: 2024

Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis.

Issue Release: 2024

Therapeutic Effects of Exosomal miRNA-4731-5p from Adipose Tissue-Derived Stem Cells on Human Glioblastoma Cells.

Issue Release: 2024

Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway.

Issue Release: 2024

Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways.

Issue Release: 2024

Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways.

Issue Release: 2024

18Beta-Glycyrrhetinic Acid Attenuates HO-Induced Oxidative Damage and Apoptosis in Intestinal Epithelial Cells via Activating the PI3K/Akt Signaling Pathway.

Issue Release: 2024

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease.

Issue Release: 2024

A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells.

Issue Release: 2024

Transplantation of Wnt5a-modified Bone Marrow Mesenchymal Stem Cells Promotes Recovery After Spinal Cord Injury via the PI3K/AKT Pathway.

Issue Release: 2024

Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations.

Issue Release: 2024

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

How Do Collaborative Care Models Work?

What Role Does Technology Play?

Why is Transitional Care Important in Pharma?

What is the Future of Patient Education in Pharma?

How are ADEs Different from Side Effects?

What Are the Challenges in Managing Chronic Conditions?

What is Regulatory Approval?

What are Collaborative Care Models?

Why is the Management of Chronic Conditions Important?

Phosphoinositide 3 Kinase (pi3k) - Pharma

Relevant Publications

Partnered Content Networks

Relevant Topics